Survival Benefit With Pembro in TNBC, but Only for Subgroup Survival Benefit With Pembro in TNBC, but Only for Subgroup

New results show a survival benefit in a subgroup of women with triple-negative breast cancer (TNBC) when pembrolizumab (Keytruda) is added to chemotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news